Noom built its brand on behavioral psychology-based weight loss through a popular consumer app, then added Noom Med in 2023 as a way for existing Noom users (and new ones) to access GLP-1 medications alongside the behavioral curriculum. The integration is structurally different from Calibrate or Found, both of which built medication-first platforms with coaching layered on top. Noom Med is the inverse — a behavioral platform with medication added as an option for patients who want it. This noom med review covers 2026 pricing, what Noom Med includes beyond the standard Noom subscription, GLP-1 access, and how Noom Med compares to Calibrate and Found for medical weight loss.
How Noom Med fits into the Noom platform
Noom’s flagship product is the standard Noom app at $70 per month or $209 per year, offering the daily lessons, food logging, behavioral coaching content, and weekly group sessions that Noom built its reputation on. Noom Med is an add-on for patients who want medical weight loss prescribing on top of the behavioral platform — the user gets the standard Noom app experience plus access to a Noom-affiliated clinician for GLP-1 evaluation and prescribing.
The integration is meaningful because Noom’s behavioral curriculum is genuinely good. The cognitive-behavioral approach to food psychology, the daily lesson structure, and the psychology-informed coaching are differentiated from generic weight loss apps. Patients who want both medication and structured behavioral content can get them in one platform. For broader weight loss telehealth context, see our telehealth guide and best telehealth for weight loss.
Noom Med pricing in 2026
Noom Med pricing is layered. The base Noom subscription is $70 per month. Noom Med adds approximately $149 per month for clinical access, totaling around $219 per month for the bundled program. Medications are separate. Compounded GLP-1s when available have ranged from $129-279 monthly through Noom Med’s pharmacy partners; branded Wegovy and Zepbound run at standard prices ($1,000+ monthly without insurance, lower with coverage).
The flexible monthly model differs from Calibrate’s 12-month commitment and is similar to Found’s structure. Patients can pause or cancel Noom Med while keeping the base Noom subscription. Insurance integration is similar to other DTC platforms — Noom doesn’t bill insurance for the program fee, and medication insurance handling is patient-driven.
What Noom Med includes
The Noom Med tier adds clinician evaluation for GLP-1 eligibility, ongoing monthly clinician check-ins via the app, prescription management, asynchronous messaging with the prescriber, and access to Noom’s pharmacy partner network. Patients also retain full access to the standard Noom features: daily lessons, food logging with the company’s calorie-density system, behavioral coaching, group sessions, and progress tracking.
The integration of behavioral content with medical care is the platform’s primary value proposition. A patient logging food in Noom can see their patterns alongside their GLP-1 dose schedule, with both pieces of data visible to the Noom Med clinician. Compared to using a separate GLP-1 platform alongside an unaffiliated weight loss app, this integration produces a more cohesive experience.
Noom Med’s clinical depth
The clinical infrastructure is reasonable but not exceptional. Noom Med uses board-certified physicians and nurse practitioners, follows current FDA labeling for GLP-1 eligibility (BMI 27+ with comorbidity or 30+ without), and screens appropriately for contraindications. The intake assessment is competent but less comprehensive than Found’s metabolic-health-focused intake or Calibrate’s 12-month structured program.
The medication formulary is narrower than Found’s. Noom Med primarily prescribes GLP-1 medications (Wegovy, Zepbound, compounded options where available) rather than the broader formulary of older weight loss medications that Found offers. Patients with insulin resistance who’d do well on metformin, or those with comorbid depression who’d benefit from bupropion, will get a less customized medication match through Noom Med than through Found. For comparison, see our Found vs Noom head-to-head.
The standard Noom app’s role
The standard Noom app’s behavioral content is genuinely the platform’s strongest asset. The cognitive-behavioral framing of food psychology, the calorie-density-based “green/yellow/red” food categorization (informed by Noom’s research with the CDC and academic partners), and the daily lesson structure produce real behavioral engagement for many users.
For patients who’d benefit from behavioral support alongside GLP-1 medication, this content is more substantive than the in-app content offered by Hims or Ro weight loss programs. Whether this content is worth the price premium over alternatives depends on whether the patient actually engages with it — Noom’s 30-day-free-trial-to-paid conversion produces high abandonment rates, and many users pay for months without using the app meaningfully.
Where Noom Med falls short
The pricing stacking is awkward. At $219+ per month for the bundle plus medication costs, Noom Med is not dramatically cheaper than alternatives, and patients who’d benefit primarily from medication access are paying for the behavioral content whether they use it or not.
The clinical depth is mid-tier. For patients with complex metabolic profiles, Found’s broader assessment and formulary produces better matched medication choices. For patients who want intensive coaching, Calibrate’s structured weekly sessions move outcomes more than Noom’s app-based content for many users. Noom Med occupies a middle position that fits patients comfortable with app-based behavioral content who want medication added on top, but doesn’t excel in any specific dimension.
Noom Med vs Calibrate, Found, Hims, and Ro
Compared to Calibrate, Noom Med has lighter clinical engagement and lighter coaching but a more flexible subscription. Calibrate’s intensive program fits patients who want and use coaching; Noom Med fits patients comfortable with app-based behavioral content. Compared to Found, Noom Med has stronger behavioral content while Found has broader medication options and stronger clinical assessment. See Noom vs Calibrate and Found vs Noom for the detailed head-to-heads.
Compared to Hims and Ro weight loss programs, Noom Med has substantially more behavioral content but less aggressive medication marketing. Hims and Ro deliver the medication access at lower total cost; Noom Med delivers integrated behavioral support at a price premium.
Frequently Asked Questions
Is Noom Med separate from regular Noom?
Noom Med is an add-on tier to the standard Noom subscription. Most users who want Noom Med subscribe to both, with the bundle pricing reflecting the combined service.
Does Noom Med prescribe Ozempic?
Noom Med primarily prescribes FDA-approved weight loss medications including Wegovy and Zepbound. Off-label Ozempic prescribing is less common since Ozempic is FDA-approved for type 2 diabetes specifically.
Does Noom Med take insurance?
Noom Med does not bill insurance for the program fee. The platform coordinates GLP-1 prescriptions where insurance can apply to the medication itself. Patients should verify their plan’s GLP-1 coverage independently.
Can I use Noom Med without the regular Noom app?
Generally no — Noom Med is structured as an add-on to the base Noom subscription. The integration of behavioral content and clinical care is the platform’s primary value proposition, and the standard Noom features are a core part of the experience.
How does Noom Med compare to Calibrate?
Noom Med leverages Noom’s stronger behavioral content but has lighter clinical engagement than Calibrate. Calibrate’s 12-month program with weekly coaching produces stronger outcomes for patients who engage; Noom Med’s flexible subscription is better for patients who want app-based behavioral support without the upfront commitment.
The bottom line on Noom Med
Noom Med is a reasonable choice for patients already engaged with the Noom app who want to add medication. The integration of behavioral content with clinical care is genuine, and the cognitive-behavioral framing fits some patients well. For patients who haven’t already adopted the Noom app, the bundle is more expensive than alternatives without dramatically better outcomes. For comprehensive medical weight loss with intensive coaching, Calibrate is structurally better. For broad medication options with lighter coaching, Found is more flexible. For pure GLP-1 access at lower cost, Hims or Ro deliver more efficiently. Noom Med fits the niche where behavioral content matters but the patient also wants medication.